SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000905718-19-000663
Filing Date
2019-08-09
Accepted
2019-08-09 16:01:30
Documents
2
Group Members
ABINGWORTH BIOVENTURES VII, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D exicure_13djul312019.htm SC 13D 73229
2 JOINT FILING AGREEMENT exicure_13djul312019ex1.htm EX-1 11871
  Complete submission text file 0000905718-19-000663.txt   86658
Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Filed by) CIK: 0001397144 (see all company filings)

IRS No.: 980518585 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13D

Mailing Address 8045 LAMON AVE, SUITE 410 SKOKIE IL 60077
Business Address 8045 LAMON AVE, SUITE 410 SKOKIE IL 60077 847-673-1700
EXICURE, INC. (Subject) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90023 | Film No.: 191012927
SIC: 2834 Pharmaceutical Preparations